Company intelligence / Profile preview

Zhejiang Ovarevive Biotechnology

Hangzhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Ovarevive Biotechnology is a clinical-stage biotechnology company based in Hangzhou, China, specializing in reproductive health and regenerative medicine. The company focuses on developing innovative cell therapies to treat conditions such as premature ovarian failure (POF) and other reproductive system disorders. Its lead candidate, OV-101, utilizes human umbilical cord mesenchymal stem cells (hUC-MSCs) to restore ovarian function and improve fertility. Ovarevive aims to address significant unmet needs in women's health through advanced stem cell research and clinical development.

Therapeutic areas: Women's Health
Modalities: Cell therapyStem cell therapyBiologic
Industry: Biotech

Drug pipeline

1 asset

OVAREVIVE II

Unknown

Beyond the preview

Go deeper on Zhejiang Ovarevive Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhejiang Ovarevive Biotechnology.

Explore the full profile